3 results
Primary: To describe safety and tolerability during longer-term administration of AR101 and follow-up observation after the last dose of AR101.Secondary: - To assess the level of desensitization achievable through extended maintenance dosing of…
Primary: To compare the efficacy of ruxolitinib versus Investigator*s choice Best Available Therapy (BAT) in patients with moderate or severe SR-cGvHD assessed by Overall Response Rate (ORR) at the Cycle 7 Day 1 visit.Secondary: To compare the rate…
1. To investigate the impact of various resistance-type exercise variables (i.e. load, repetitions, volume) on skeletal muscle mass, strength and physical performance outcomes in (mal)nourished frail community-dwelling older adults.2. To investigate…